CoChat

Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis

Teede, Helena J., McGrath, Barry P., Smolich, Joseph J., Malan, Erica, Kotsopoulos, Dimitra, Liang, Yu-Lu, Peverill, Roger E. · 2000 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 132

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Abstract —Hormone replacement therapy (HRT) appears to be cardioprotective in postmenopausal women; however, concerns exist over its thrombogenic effects. To address the effects of combined HRT on coagulation and fibrinolysis, we have measured circulating markers of these processes in a double-blind placebo-controlled trial. Forty-two healthy postmenopausal women aged 50 to 75 years received continuous combined HRT with 2 mg estradiol+1 mg norethisterone or placebo for 6 weeks. Hormone profiles were measured at baseline, and lipid and hemostatic parameters were measured at baseline and after 6 weeks of therapy. Baseline characteristics were similar in the 2 groups. With change from baseline the main outcome measure , HRT increased the markers of coagulation (prothrombin fragments 1+2, 0.20±0.06 versus 0.06±0.04 nmol/L, P =0.0005; soluble fibrin, 2.3±0.4 versus 0.25±0.3 μg/mL, P =0.0004), reduced plasma fibrinolytic inhibitory activity (plasminogen activator inhibitor-1, −0.67±0.16 versus 0.24±0.21 U/mL, P =0.002), and increased fibrinolysis (D-dimer, 24±12 versus −6±8 ng/mL, P =0.04) compared with placebo. Increases in soluble fibrin and D-dimer were positively correlated ( r =0.59, P =0.02), but changes in plasminogen activator inhibitor-1 and D-dimer were unrelated. Although baseline hemostatic and lipid parameters were correlated, there were no associations between changes in hemostatic markers and lipids after treatment. Short-term oral combined continuous HRT (estradiol and norethisterone) increased thrombin and fibrin generation, reduced plasma fibrinolytic inhibitory activity, and increased fibrinolysis. Enhanced fibrinolysis was related to increased fibrin generation but not reduced plasma fibrinolytic inhibitory activity. Coagulation activation may partly explain the increases in venous thrombosis and cardiovascular events reported with the use of combined HRT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.20.5.1404

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 132

Metadata

Authors
Teede, H. J., McGrath, B. P., Smolich, J. J., Malan, E., Kotsopoulos, D., Liang, Y.-L., & Peverill, R. E.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2000-05
Volume
20
Issue
5
Pages
1404-1409
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2064120200
Cited by
132
References
3
FWCI
11.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis. https://app.cochat.ai/papers/10.1161/01.atv.20.5.1404
The paper
Teede, H. J., McGrath, B. P., Smolich, J. J., Malan, E., Kotsopoulos, D., Liang, Y.-L., & Peverill, R. E. (2000). Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.20.5.1404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.